Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 5 for:    brigham and women's hospital | Gynecologic Cancer

Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03277482
Recruitment Status : Recruiting
First Posted : September 11, 2017
Last Update Posted : March 5, 2020
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Larissa Lee, MD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 1, 2021
Estimated Study Completion Date : November 1, 2021